. The foetal-specific light chain, as shown by one-dimensional-peptide-map analysis, is structurally unrelated to both LC1S and LC1F light chains of human adult myosin. We conclude from these results that the ontogenesis of human muscle myosin shares certain common features with that observed in other species, except for the persistence until birth of a foetal form of heavy chain (HCemb.).
lian species, for which the existence of embryonic/ foetal, neonatal, adult slow and adult fast isomyosins is now well documented (Whalen et al., 1981; Lowey et al., 1983; Caplan et al., 1983) . The evidence for myosin heterogeneity with respect to the heavy chains and at various stages of muscle development, comes mainly from electrophoretic studies of human native myosin in pyrophosphate gels (Fitzsimons & Hoh, 1981a) . On the other hand, the nature of the associated light chains in the myosin of immature human muscle has been investigated in greater detail. We have shown (Volpe et al., 1981 , and this has been Abbreviations used: LC, (myosin) light chain; SDS, sodium dodecyl sulphate; e.l.i.s.a., enzyme-linked immunosorbent assay; HC, (myosin) heavy chain; phosphate-buffered saline, 0.1 M-sodium phosphate/ 0.15M-NaCl, pH 7.2; LCemb., foetal-specific light chain. t To whom correspondence and reprint requests should be addressed.
confirmed recently by Strohman et al. (1983) , that the two main light chains in human foetal myosin are those predominant in pure adult fast myosin, similar to other species (see Lowey et al., 1983) . A minor light-chain component, specific to human foetal myosin, has also been identified and tentatively classified as a slow type of light chain (Strohman et al., 1983) , possibly related to the LC1 light chain of human foetal or adult atrium and foetal ventricle (Cummins, 1983) . We report here on the characterization of the heavy chains of human foetal and neonatal myosin by direct electrophoresis in SDS/polyacrylamide gels, peptide-mapping analysis and, as a complementary approach, by specific antibodies using e.l.i.s.a., and Western-blot immunoenzymicstaining techniques. Furthermore, we show that the human foetal-specific myosin light chain is structurally and antigenically different from the LC1 light-chain components of adult myosin.
Parts of this work have been presented at an International Symposium on Muscular Dystrophy held in Modena, Italy, in 1983 (Margreth et al., 1984 
Preparative procedures
Myosin was prepared from human skeletal muscles by the method of Barany & Close (1971) , as described previously (Volpe et al., 1981) , in the presence of pepstatin (200pg/litre) in the extraction and purification media. Myosins were stored in 5 mM-Tris/HCl buffer (pH 7.6)/25 mM-KCl/ 0.05 mM-dithiothreitol/50% glycerol at -20°C, unless immediately used.
Electrophoresis
SDS/polyacrylamide-gel electrophoresis was carried out by using Laemmli's (1970) method in 0.75mm-thick 5%-or 15%-(w/v)-polyacrylamide slab gels. Two-dimensional electrophoresis was carried out by the method of O'Farrell (1975) , under conditions identical with those reported by Volpe et al. (1981) . One-dimensional peptide maps of myosin heavy and light chains were performed under the general conditions of Cleveland et al. (1977) , or with the modifications of Carraro et al. (1981) , after partial digestion with Staphylococcus aureus V8 proteinase, in a 1mm-thick 15-20%-polyacrylamide-linear-gradient slab gel. Slab gels were stained with either Coomassie Blue or by the silver nitrate method described by Merril et al. (1981) .
Preparation ofantisera and purification ofantibodies Affinity-purified antibodies to rabbit LC1F were the same as those previously characterized (Volpe et al., 1981; Biral et al., 1982) .
Antisera to purified human foetal myosin were raised in adult hens by three intramuscular injections at 2-week intervals of 1 mg of antigen emulsified with an equal volume of complete Freund's adjuvant. Antibodies were purified by affinity chromatography as described by Volpe et al. (1981) . The batch of antibodies used in the present study was from a single bleeding.
The preparation of antisera and purification of antibodies against purified rabbit soleus myosin followed procedures identical with those reported above for human foetal myosin. Immunological techniques (1) E.l.i.s.a. One-step non-competitive and twostep competitive e.l.i.s.a. immunoassays were carried out under conditions identical with those described by Biral et al. (1982) . (2) (Rushbrook 1984 & Stracher, 1979 and rat (Carraro & Catani, 1983) muscle.
The presence of two components in the heavychain region of electrophoretograms of the myosin of human adult mixed muscle ( Fig. 1) , and the greater prominence of the slower-moving band in vastus lateralis, a predominantly fast muscle (Volpe et al., 1981) , are in agreement with the results of Carraro & Catani (1983) . In particular, differences in relative mobility between adult fast and slow forms were observed. Neither of these components was detectable in human neonatal myosin, which contained instead a single heavychain form of intermediate mobility (Fig. 1) . On the other hand, foetal myosin, as well as myosin from a premature infant, were contradistinguished by the presence of trace amounts of an additional heavy-chain component that co-migrated with the faster-moving heavy-chain band of adult myosin. Interestingly, this band was found to be much more pronounced in electrophoretograms of muscle myosin from an anencephalic infant ( Fig. 1) .
Immunoenzymic staining of blots of the electrophoretic gels with antibodies against rabbit slow myosin ( Fig. 2) showed that the faster-moving electrophoretic band, but no other heavy-chain band, was cross-reactive, irrespective of the myosin source. In further experiments the whole myosin was probed with these antibodies by e.l.i.s.a. techniques. It was found that, in a range of antibody concentrations of 0.1-10pg of protein, and at a fixed coating concentration of antigen (5pg/ml), adult and anencephalic neonatal myosin were the most reactive, normal neonatal myosin the weakest, and foetal myosin of intermediate reactivity. Thus both lines of evidence supported the conclusion that foetal myosin, but not normal (a) neonatal myosin, contains a slow heavy-chain component.
Peptide mapping of myosin heavy chains was done by the procedure of Cleveland et al. (1977) , after partial digestion, with S. aureus V8 proteinase, of the overall heavy-chain band material cut off a preparative 15%-polyacrylamide slab gel (see the Materials and methods section). The results (Fig. 3) Fig. 1 . Electrophoretic analysis of myosin heavy chains of human developing and adult muscles SDS/5% (w/v)-polyacrylamide-slab-gel electrophoresis of myosins was performed as described in the Materials and methods section. Key to muscle myosins: (i) foetal muscle; (ii) normal neonatal muscle; (iii) co-electrophoresis of (i)+(ii); (iv) anencephalic neonatal muscle; (v) immature neonatal muscle; (vi) co-electrophoresis of (i)+(iv); (vii) co-electrophoresis of (i)+(v); (viii) normal adult muscle (vastus lateralis). About 200ng of protein were loaded per well. The slab was stained with silver nitrate as described by Merril et al. (1981) (Fig. 4a) . When resolved by electrophoresis in SDS/5%-polyacrylamide gels, the two forms of adult heavy chains were only weakly stained by the antibody, as compared with the foetal-specific heavy chain (Fig. 4b) . As shown by immunoenzymic staining of blots of S. aureus V8 proteinase digests of the foetal-specific heavy chain with anti-(human foetal myosin) affinity-purified antibody, the antigenic determinants appeared to be distributed among several peptides, presumably derived from different domains of the heavy chains (Fig. 4c) .
As shown in Fig. 5 (Fig. Sb) . As expected, the extent of immunological crossreactivity of anencephalic neonatal myosin with foetal myosin, was found to be decreased, by about one order of magnitude, as compared with normal neonatal myosin (Fig. 5b) . (b) Light-chain complement of human foetal and neonatal myosins
In view of the recent demonstration of a foetalspecific light chain in the myosin of human immature muscle (Strohman et al., 1983; Cummins, 1983 ), we re-examined the light-chain pattern of foetal and neonatal myosins against that of adult myosin.
When analysed by one-dimensional electrophoresis in slightly overloaded slab gels (Fig. 6) , both foetal and neonatal myosins gave rise to two main components in the light-chain region, representing the LC1F and LC2F light chains of adult myosin, in agreement with our earlier observations (Volpe et al., 1981) . Foetal myosin contained two additional light-chain components: a LC2S light chain and the previously described (Strohman et al., 1983; Cummins, 1983) LCemb.. Although neither of these two light chains appeared to be a normal component of muscle myosins of term and premature infants, the LC2S-light-chain band was found to be particularly prominent in muscle myosins from an anencephalic infant (Fig. 6) . It was verified that all these differences between foetal and neonatal myosins were maintained after one purification cycle of the myosin preparations in pyrophosphate gels as described by Hoh (1978) and Fitzsimons & Hoh (1981a) .
The results of Fig. 6 indicate an apparent Mr for human myosin LCemb. of about 27000, which is higher than that of LC1F and at variance with the situation in the rat (Whalen et al., 1978 sional gel electrophoresis (Fig. 7) , human LC1Sa is contradistinguished by a very low isoelectric point, this also being lower than that of its rabbit slowmyosin homologue. These findings once more emphasize the existence of species-specific peculiarities of human myosin light chains (Volpe et al., 1981) .
(c) Antigenic and structural relationship between foetal-specific and adult myosin light chains
The antigenic and structural relationship between human myosin LCemb. and the LC1 components of adult slow skeletal muscle (Strohman et al., 1983) and atrial muscle (Cummins, 1983) myosin is still controversial.
Immunoenzymic staining of the electrophoretically separated light chains of human foetal myosin with anti-(rabbit LC1F) antibody (Fig. 7) revealed that antibody staining is much weaker for the foetal-specific light chain, as compared with LC1F, and qualitatively similar to that of LC2F, already shown to be weakly cross-reactive with anti-(rabbit LC1F) antibody by e.l.i.s.a. techniques (Biral et al., 1982) .
A structural heterogeneity between human foetal-specific light chain, LC1F, and the LC1S light chain is supported by the results obtained by peptide-map analysis. In these experiments, the foetal-specific light chain band, LC1F, and the overall LC1S material (predominantly LClSb) were cut out from preparative slab gels of myosin preparations from foetal, neonatal and adult muscle, and digested with S. aureus V8 proteinase. One-dimensional-peptide-map analysis (Fig. 8) [Myosin] (,ug/ml) Fig. 5 . Immunological cross-reactivities of the myosins of immature and adult muscles with anti-(human foetal myosin) antibody by e.l.i.s.a. techniques (a) One step e.l.i.s.a. The immunoassay was carried out at antigen concentrations identical to those in Fig. 3 and at the concentrations of affinity-purified anti-(human foetal myosin) antibody indicated on the abscissa. (b) Two-step competitive e.l.i.s.a. The immunoassay was carried out as previously described (Biral et al., 1982) . Myosins, at the final concentrations indicated on the abscissa, were preincubated with anti-(human foetal myosin) antibody (5 pg of protein/ml). After incubating for 16h, the second step was performed with microtitre wells coated with human foetal myosin (5yg/ml). Key to muscle myosins: 0, foetal muscle; 0, normal neonatal muscle; Ol, immature neonatal muscle; *, anencephalic newborn; A, normal adult muscle (pectoralis minor). . SDS/polyacrylamide-gel electrophoresis of human muscle myosins One-dimensional SDS/polyacrylamide-gel electrophoresis of muscle myosins was carried out in 15%-polyacrylamide slab gels as described by Laemmli (1970) . , 1982) . At variance with the situation in other mammalian species (e.g. the rabbit and the rat; results not shown), the peptide-map pattern of human LClF appeared also to be qualitatively similar to that of its slow-type homologue (Fig. 8) .
On the other hand, the foetal-specific light chain exhibited a unique peptide pattern in all respects (Fig. 8) .
Discussion
The results reported here, along with previous findings reported in the literature, outline certain common features as well as differences between human developing muscle and embryonic and neonatal muscle of other species.
The existence of an embryonic form of myosin light chain in human foetal muscle (Cummins, 1983; Strohman et al., 1983 ) is confirmed by our present results and appears to be a common feature of myosin ontogenesis in mammalian, but not in avian, species (Whalen et al., 1978; Gauthier et al., 1982; see also Caplan et al., 1983 , for a review). In all species where it was demonstrated, its disappearance from myosin appears to be coincident with developmental periods at or around birth, as was also shown in the present study. Myosin LCemb. has unique structural properties and, superimposed on these, species-specific features. Our results show that the peptide-map pattern of human LCemb. is quite distinct from that of adult myosin LC1 components, thus disputing the suggested classification of this light chain as a slow type of light chain (Strohman et al., 1983 ). We also demonstrate that this light chain, unlike its rat homologue (Whalen et al., 1978) , has an isoelectric point identical with, but a greater molecular size than, that of LC1F. Because of these variations in structural details depending on the species, it may therefore be premature to exclude the possibility that a hitherto-unidentified embryonic form of myosin light chain may be synthesized during early muscle ontogenesis in non-mammalian species. A problem that has been at the origin of much controversy is the co-expression, in early developing muscle, of adult slow-type light chains (Stockdale et al., 1981; Gauthier et al., 1982 ; see also Caplan et al., 1983) . In human foetal muscle we also find a trace amount of LC2S, and the parallel observation of an adult slow electrophoretic form of heavy chain immunologically cross-reactive with the adult form suggests that a slow myosin isoenzyme is a normal component of early muscle myosin.
However, in spite of these analogies, interpretation of our findings is made difficult by the recent demonstration that embryonic slow myosin has a different heavy-chain peptide composition from that of the adult slow form . This also depends on the future differentiation of the muscles (Lyons et al., 1983) . Furthermore, our results indicate that the slow myosin component does not normally persist in neonatal muscle, except in muscle from an anencephalic infant, an observation that might suggest that, under these conditions at least, an altered pattern of discharge of spinal motoneurons due to the suppression of suprasegmental influences is the responsible factor. That would be contrary to the now-prevailing view Lyons et al., 1983 ) that non-neural intrinsic factors regulate the expression of myosin genes in early skeletal muscle. However, our results do not necessarily imply that the nature of the slow myosin component is the same for foetal and pathological neonatal muscle.
With regard to transitions of myosin isoenzymes from foetal to neonatal life, our present results provide definitive evidence that, in leg muscle of full-term infants, only LC 1 F and LC2F are expressed, an observation similar to that in other species (Whalen et al., 1981; Stockdale et al., 1981; Gauthier et al., 1982) , and that the associated heavy chains are of a distinctive type from adult fast and slow myosin heavy chains. Nevertheless, there is no evidence to indicate that, in humans, the 'neonatal' form of myosin heavy chains is structurally and antigenically different from the predominant foetal form. That is apparently in contradiction with knowledge of the sequential appearance of an embryonic and a neonatal form of myosin heavy chain during muscle development, as originally described by Whalen et al. (1981) in the rat. The chronological sequence, in absolute times, of these transitions, was, however, shown to vary considerably according to the species , as well as between future fast and slow muscles of the rat (Lyons et al., 1983) .
Owing to the inherent limitations of the analytical techniques used, we cannot entirely exclude the existence of subtle structural differences between human foetal and neonatal heavy chains. However, an alternative explanation is that, in the human species, which spends a considerable time 1984 930 00i to reach full maturity, an embryonic/foetal form of myosin heavy chains may persist in muscle until birth and be substituted by a 'neonatal' form at later periods of postnatal life.
